1. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human reproduction (Oxford, England). 2011;26(7):1616-1624.
2. Kawamura K, Ishizuka B, Hsueh AJW. Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve. Reproductive biomedicine online. 2020;40(2):245-253.
3. Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction (Cambridge, England). 2004;127(2):239-254.
4. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction (Cambridge, England). 2006;132(2):191-206.
5. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocrine reviews. 2004;25(1):72-101.
6. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996;383(6600):531- 535.
7. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Molecular and cellular endocrinology. 2001;179(1-2):39-46.
8. Juengel JL, Hudson NL, Heath DA, et al. Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biology of reproduction. 2002;67(6):1777-1789.
9. Hernández-Coronado CG, Guzmán A, Castillo-Juárez H, Zamora-Gutiérrez D, RosalesTorres AM. Sphingosine-1-phosphate (S1P) in ovarian physiology and disease. Annales d'endocrinologie. 2019;80(5-6):263-272.
10. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. American journal of human genetics. 2004;75(1):106-111.
11. Shi J, Yoshino O, Osuga Y, et al. Bone morphogenetic protein-2 (BMP-2) increases gene expression of FSH receptor and aromatase and decreases gene expression of LH receptor and StAR in human granulosa cells. American journal of reproductive immunology (New York, NY : 1989). 2011;65(4):421-427.
12. Shi J, Yoshino O, Osuga Y, et al. Bone morphogenetic protein-6 stimulates gene expression of follicle-stimulating hormone receptor, inhibin/activin beta subunits, and anti-Mullerian hormone in human granulosa cells. Fertility and sterility. 2009;92(5):1794- 1798.
13. Shi J, Yoshino O, Osuga Y, Nishii O, Yano T, Taketani Y. Bone morphogenetic protein 7 (BMP-7) increases the expression of follicle-stimulating hormone (FSH) receptor in human granulosa cells. Fertility and sterility. 2010;93(4):1273-1279.
14. Rico-Llanos GA, Becerra J, Visser R. Insulin-like growth factor-1 (IGF-1) enhances the osteogenic activity of bone morphogenetic protein-6 (BMP-6) in vitro and in vivo, and together have a stronger osteogenic effect than when IGF-1 is combined with BMP-2. Journal of biomedical materials research Part A. 2017;105(7):1867-1875.
15. Spiegel S, Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. The Journal of biological chemistry. 2002;277(29):25851-25854.
16. Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010;24(9):862-874.
17. Yu FX, Zhao B, Panupinthu N, et al. Regulation of the Hippo-YAP pathway by G-proteincoupled receptor signaling. Cell. 2012;150(4):780-791.
18. Cheng Y, Feng Y, Jansson L, et al. Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2015;29(6):2423-2430.
19. Becker S, von Otte S, Robenek H, Diedrich K, Nofer JR. Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1. Biology of reproduction. 2011;84(3):604-612.
20. Nakahara T, Iwase A, Nakamura T, et al. Sphingosine-1-phosphate inhibits H2O2- induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. Fertility and sterility. 2012;98(4):1001-1008.e1001.
21. Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nature chemical biology. 2010;6(7):489-497.
22. Olivera A, Kohama T, Edsall L, et al. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. The Journal of cell biology. 1999;147(3):545-558.
23. Ito M, Yoshino O, Ono Y, et al. Bone morphogenetic protein-2 enhances gonadotropinindependent follicular development via sphingosine kinase 1. American journal of reproductive immunology (New York, NY : 1989). 2020:e13374.
24. Bayasula, Iwase A, Kiyono T, et al. Establishment of a human nonluteinized granulosa cell line that transitions from the gonadotropin-independent to the gonadotropin-dependent status. Endocrinology. 2012;153(6):2851-2860.
25. Nakashima A, Yamanaka-Tatematsu M, Fujita N, et al. Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia. Autophagy. 2013;9(3):303-316.
26. Kotsuji F, Tominaga T. The role of granulosa and theca cell interactions in ovarian structure and function. Microscopy research and technique. 1994;27(2):97-107.
27. Orisaka M, Mizutani T, Tajima K, et al. Effects of ovarian theca cells on granulosa cell differentiation during gonadotropin-independent follicular growth in cattle. Molecular reproduction and development. 2006;73(6):737-744.
28. Fan Q, Cheng Y, Chang HM, Deguchi M, Hsueh AJ, Leung PCK. Sphingosine-1- phosphate promotes ovarian cancer cell proliferation by disrupting Hippo signaling. Oncotarget. 2017;8(16):27166-27176.
29. Nakashima A, Cheng SB, Kusabiraki T, et al. Endoplasmic reticulum stress disrupts lysosomal homeostasis and induces blockade of autophagic flux in human trophoblasts. Scientific reports. 2019;9(1):11466.
30. Nakashima A, Higashisaka K, Kusabiraki T, et al. Autophagy is a new protective mechanism against the cytotoxicity of platinum nanoparticles in human trophoblasts. Scientific reports. 2019;9(1):5478.
31. Nakashima A, Cheng SB, Ikawa M, et al. Evidence for lysosomal biogenesis proteome defect and impaired autophagy in preeclampsia. Autophagy. 2019:1-15.
32. Brodowska K, Al-Moujahed A, Marmalidou A, et al. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. Experimental eye research. 2014;124:67-73.
33. Kwong EK, Li X, Hylemon PB, Zhou H. Sphingosine kinases/sphingosine 1-phosphate signaling in hepatic lipid metabolism. Current pharmacology reports. 2017;3:176-183.
34. Selvaraju S, Folger JK, Gupta PS, Ireland JJ, Smith GW. Stage-specific expression and effect of bone morphogenetic protein 2 on bovine granulosa cell estradiol production: regulation by cocaine and amphetamine regulated transcript. Domestic animal endocrinology. 2013;44(3):115-120.
35. Sugiyama R, Fuzitou A, Takahashi C, et al. Bone morphogenetic protein 2 may be a good predictor of success in oocyte fertilization during assisted reproductive technology. Human cell. 2010;23(3):83-88.
36. Yang J, Xu S, Chen M, et al. Serum sclerostin and bone morphogenetic protein-2 levels in patients with ankylosing spondylitis: a meta-analysis. Calcified tissue international. 2019;105(1):37-50.
37. Jungbluth P, Grassmann JP, Thelen S, et al. Concentration of platelets and growth factors in platelet-rich plasma from Goettingen minipigs. GMS Interdisciplinary plastic and reconstructive surgery DGPW. 2014;3:Doc11.
38. Scotti L, Di Pietro M, Pascuali N, et al. Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndrome. Molecular human reproduction. 2016;22(12):852-866.
39. Punsawad C, Viriyavejakul P. Reduction in serum sphingosine 1-phosphate concentration in malaria. PloS one. 2017;12(6):e0180631.
40. von Otte S, Paletta JR, Becker S, et al. Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. The Journal of biological chemistry. 2006;281(9):5398-5405.
41. Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Human reproduction (Oxford, England). 1986;1(2):81-87.
42. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocrine reviews. 2000;21(2):200-214.
43. Hernandez-Coronado CG, Guzman A, Rodriguez A, et al. Sphingosine-1-phosphate, regulated by FSH and VEGF, stimulates granulosa cell proliferation. General and comparative endocrinology. 2016;236:1-8.
44. Rossi RO, da Cunha EV, Portela AM, et al. Influence of BMP-2 on early follicular development and mRNA expression of oocyte specific genes in bovine preantral follicles cultured in vitro. Histology and histopathology. 2016;31(3):339-348.
45. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. The Journal of biological chemistry. 2000;275(50):39523-39528.
46. McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). International orthopaedics. 2007;31(6):729-734.
47. Jung T, Lee JH, Park S, et al. Effect of BMP-2 delivery mode on osteogenic differentiation of stem cells. Stem cells international. 2017;2017:7859184.
48. Kim HY, Lee JH, Yun JW, et al. Development of porous beads to provide regulated BMP2 stimulation for varying durations: in vitro and in vivo studies for bone regeneration. Biomacromolecules. 2016;17(5):1633-1642.
49. James AW, LaChaud G, Shen J, et al. A review of the clinical side effects of bone morphogenetic protein-2. Tissue engineering Part B, Reviews. 2016;22(4):284-297.
50. Takahashi Y, Yamamoto M, Tabata Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta- tricalcium phosphate. Biomaterials. 2005;26(23):4856-4865.